(Q43480378)

23 November 2017

title

SuPAR and PAI-1 in critically ill, mechanically ventilated patients (English)

1 reference

23 November 2017

Ville Jalkanen

1

1 reference

23 November 2017

Runkuan Yang

2

1 reference

23 November 2017

Rita Linko

3

1 reference

23 November 2017

Heini Huhtala

4

1 reference

23 November 2017

Marjatta Okkonen

5

1 reference

23 November 2017

Tero Varpula

6

1 reference

23 November 2017

Ville Pettilä

7

1 reference

23 November 2017

Jyrki Tenhunen

8

1 reference

23 November 2017

FINNALI Study Group

9

1 reference

23 November 2017

publication date

26 October 2012

1 reference

23 November 2017

published in

Intensive Care Medicine

1 reference

23 November 2017

volume

39

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

489-496

1 reference

Regulation of cell signalling by uPAR.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Coagulation, fibrinolysis, and fibrin deposition in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Acute respiratory distress syndrome and acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Acute respiratory failure in intensive care units. FINNALI: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Long-term stability of fibrinolytic factors stored at -80 degrees C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

A randomized controlled clinical trial to evaluate the efficacy, safety, cost-effectiveness and effect on PAI-1 levels of the three low-molecular-weight heparins--enoxaparin, nadroparin and dalteparin. The ESCAPe-END study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-012-2730-X

Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis

21 January 2018

1 reference

12 December 2020

suPAR: the molecular crystal ball

1 reference

12 December 2020

TAFI and PAI-1 levels in human sepsis

1 reference

12 December 2020

Soluble urokinase plasminogen activator receptor measurements: influence of sample handling.

1 reference

12 December 2020

Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects

1 reference

12 December 2020

Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study

1 reference

12 December 2020

10.1007/S00134-012-2730-X

Identifiers

DOI

1 reference

23 November 2017

1 reference